1. Shechter SM, Chandler T, Skandari MR, Zalunardo N. The cost-effectiveness analysis of vascular access referral policies in chronic kidney disease. To appear in American Journal of Kidney Diseases.
  2. Sabouri A, Huh WT, Shechter SM. Screening strategies for patients on the kidney transplant waiting list. To appear in Operations Research.
  3. Skandari R, Shechter SM, Zalunardo N. Optimal vascular access choice for patients on hemodialysis. Manufacturing and Service Operations Management, 17(4): 608-619, 2015. Paper
  4. Sabouri A, Shechter SM, Huh WT. Inspecting a vital component needed upon emergency. Production and Operations Management, 24(12): 1839-1851, 2015. Paper
  5. Shechter SM, Ghassemi F, Gocgun Y, Puterman ML. Trading off quick versus slow actions in optimal search. Operations Research, 63(2): 353-362, 2015. Paper
  6. Nagarajan M, Shechter S. Prospect theory and the newsvendor problem. Management Science, 60(4): 1057-1062, 2014. Paper
  7. Shechter SM, Skandari MR, Zalunardo N. Timing of arteriovenous fistula creation in patients with chronic kidney disease: A decision analysis. American Journal of Kidney Diseases, 63(1): 95-103, 2014. Paper
  8. Regnier ED, Shechter S. State-space size considerations for disease-progression models. Statistics in Medicine, 32(22): 3862-3880, 2013. Paper
  9. Icten GZ, Shechter SM, Maillart LM, Nagarajan M. Optimal management of a limited number of replacements under Markovian deterioration. IIE Transactions, 45(2): 206-214, 2013. Paper
  10. Saveh-Shemshaki F, Shechter S, Tang P, Isaac-Renton J. Setting sites for faster results: Optimizing locations and capacities of new tuberculosis testing laboratories. IIE Transactions in Health Systems Engineering, 2(4): 248-258, 2012. Paper
  11. Shechter SM, Huh WT, Slofstra A. Simultaneous testing of multicharacteristic components. Operations Research Letters, 40(5): 411-415, 2012. Paper
  12. Shechter SM. Efficient solution procedures for a class of optimal stopping problems. Operations Research Letters, 40(5): 409-410, 2012. Paper
  13. Werker G, Sauré A, French J, Shechter S. The use of discrete-event simulation modelling to improve radiation therapy planning processes. Radiotherapy and Oncology, 92(1): 76-82, 2009. Paper
  14. Shechter SM, Bailey MD, Schaefer AJ. Replacing nonidentical vital components to extend system life. Naval Research Logistics, 55: 700-703, 2008. Paper
  15. Shechter SM, Bailey MD, Schaefer AJ. A modeling framework for replacing medical therapies. IIE Transactions, 40(9): 861-869, 2008. Paper
  16. Shechter SM, Bailey MD, Schaefer AJ, Roberts MS. The optimal time to initiate HIV therapy under ordered health states. Operations Research, 56(1): 20-33, 2008. Paper
  17. Braithwaite RS, Roberts MS, Chang CCH, Goetz MB, Gilbert CL, Rodriguez-Barradas MC, Shechter S, Schaefer A, Nucifora K, Koppenhaver R, Justice AC. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model. Annals of Internal Medicine, 148(3): 178-185, 2008. Paper
  18. Braithwaite RS, Conigliaro J, Roberts MS, Shechter S, Schaefer A, McGinnis K, Rodriguez MC, Rabenek L, Bryant K, Justice AC. Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care, 19(4): 459-466, 2007. Paper
  19. Braithwaite RS, Shechter S, Chang CCH, Schaefer A, Roberts MS. Estimating the rate of accumulating drug resistance mutations in the HIV genome. Value in Health, 10(3): 204-213, 2007. Paper
  20. Braithwaite RS, Shechter S, Roberts MS, Schaefer A, Bangsberg DR, Harrigan PR, Justice AC. Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation. Journal of Antimicrobial Chemotherapy, 58: 1036-1043, 2006. Paper
  21. Shechter SM, Schaefer AJ, Braithwaite RS, Roberts MS. Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques. Medical Decision Making, 26(5): 550-553, 2006. Paper
  22. Bailey MD, Schaefer AJ, Shechter SM. SPAR: stochastic programming with adversarial recourse. Operations Research Letters, 34(3): 307-315, 2006. Paper
  23. Shechter SM, Bryce CL, Alagoz O, Kreke JE, Stahl JE, Schaefer AJ, Angus DC, Roberts MS. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Medical Decision Making, 25(2): 199-209, 2005. Paper
  24. Stahl JE, Kong N, Shechter SM, Schaefer AJ, Roberts MS. A methodological framework for optimally reorganizing liver transplant regions. Medical Decision Making, 25(1): 35-46, 2005. Paper
  25. Alagoz O, Bryce CL, Shechter S, Schaefer A, Chang CCH, Angus DC, Roberts MS. Incorporating biological natural history in simulation models: Empirical estimates of the progression of end-stage liver disease. Medical Decision Making, 25(6): 620-632, 2005. Paper


  1. Shechter SM, Braithwaite RS, Schaefer AJ, Roberts MS. Modeling the progression and treatment of HIV. Proceedings of the 2004 Winter Simulation Conference, Ingalls RG, Rossetti MD, Smith JS, Peters BA, eds., p. 953-959, 2004.


  1. Shechter SM. Monte Carlo simulation as an aid for deciding among treatment options. Encyclopedia of Operations Research and Management Science.
  2. Schaefer AJ, Bailey MD, Shechter SM, Roberts MS. Modeling medical treatment using Markov decision processes, Chapter 23 in Operations Research and Health Care: A Handbook of Methods and Applications. Brandeau M, Sainfort F, Pierskalla W, eds., Kluwer, Boston, p. 593-612, 2004.